Evidence-Based Treatment of Metastatic Gastric Cancer

home / insights / treatment-of-metastatic-gastric-cancer
Global Use of Frontline Therapy in Metastatic Gastric Cancer

EP. 1: Global Use of Frontline Therapy in Metastatic Gastric Cancer

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Metastatic Gastric Cancer: Factors in Selecting Frontline Therapy

EP. 2: Metastatic Gastric Cancer: Factors in Selecting Frontline Therapy

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Is Frontline IO Therapy Appropriate in Gastric Cancer?

EP. 3: Is Frontline IO Therapy Appropriate in Gastric Cancer?

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Gastric Cancer: Global Perspectives on Maintenance Therapy

EP. 4: Gastric Cancer: Global Perspectives on Maintenance Therapy

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Switch Maintenance in Gastric Cancer: Results of JAVELIN Gastric 100

EP. 5: Switch Maintenance in Gastric Cancer: Results of JAVELIN Gastric 100

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Metastatic Gastric Cancer: Identifying Disease Progression

EP. 6: Metastatic Gastric Cancer: Identifying Disease Progression

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Global Use of Second-Line Therapy in mGC

EP. 7: Global Use of Second-Line Therapy in mGC

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Chemotherapy + Ramucirumab as Second-Line Therapy in mGC

EP. 8: Chemotherapy + Ramucirumab as Second-Line Therapy in mGC

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Later Lines of Therapy in Metastatic Gastric Cancer

EP. 9: Later Lines of Therapy in Metastatic Gastric Cancer

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Emerging Biomarkers in Metastatic Gastric Cancer

EP. 10: Emerging Biomarkers in Metastatic Gastric Cancer

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Metastatic Gastric Cancer: Promising Frontline Trials

EP. 11: Metastatic Gastric Cancer: Promising Frontline Trials

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Gastric Cancer: Frontline Checkpoint Inhibitor Trials

EP. 12: Gastric Cancer: Frontline Checkpoint Inhibitor Trials

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Metastatic Gastric Cancer: Novel Agents Targeting FGF

EP. 13: Metastatic Gastric Cancer: Novel Agents Targeting FGF

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Metastatic Gastric Cancer: Promising Second-Line Trials

EP. 14: Metastatic Gastric Cancer: Promising Second-Line Trials

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Metastatic Gastric Cancer: Promising Later-Line Trials

EP. 15: Metastatic Gastric Cancer: Promising Later-Line Trials

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Perioperative Strategies in Metastatic Gastric Cancer

EP. 16: Perioperative Strategies in Metastatic Gastric Cancer

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020
Metastatic Gastric Cancer: Recent Advances and Future Directions

EP. 17: Metastatic Gastric Cancer: Recent Advances and Future Directions

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center;Daniel V. Catenacci, MD, University of Chicago;David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center;Kei Muro, MD, Aichi Cancer Center Hospital
June 2nd 2020